These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1081 related articles for article (PubMed ID: 26055855)

  • 1. Risk Factors for Recurrent Urinary Tract Infection and Renal Scarring.
    Keren R; Shaikh N; Pohl H; Gravens-Mueller L; Ivanova A; Zaoutis L; Patel M; deBerardinis R; Parker A; Bhatnagar S; Haralam MA; Pope M; Kearney D; Sprague B; Barrera R; Viteri B; Egigueron M; Shah N; Hoberman A
    Pediatrics; 2015 Jul; 136(1):e13-21. PubMed ID: 26055855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal Scarring in the Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) Trial.
    Mattoo TK; Chesney RW; Greenfield SP; Hoberman A; Keren R; Mathews R; Gravens-Mueller L; Ivanova A; Carpenter MA; Moxey-Mims M; Majd M; Ziessman HA;
    Clin J Am Soc Nephrol; 2016 Jan; 11(1):54-61. PubMed ID: 26555605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of vesicoureteral reflux and renal scarring in urinary tract infections.
    Yılmaz İ; Peru H; Yılmaz FH; Sekmenli T; Çiftçi İ; Kara F
    Arch Argent Pediatr; 2018 Aug; 116(4):e542-e547. PubMed ID: 30016028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent Urinary Tract Infections in Children With Bladder and Bowel Dysfunction.
    Shaikh N; Hoberman A; Keren R; Gotman N; Docimo SG; Mathews R; Bhatnagar S; Ivanova A; Mattoo TK; Moxey-Mims M; Carpenter MA; Pohl HG; Greenfield S
    Pediatrics; 2016 Jan; 137(1):. PubMed ID: 26647376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Swedish infant high-grade reflux trial: UTI and renal damage.
    Nordenström J; Sjöström S; Sillén U; Sixt R; Brandström P
    J Pediatr Urol; 2017 Apr; 13(2):146-154. PubMed ID: 28215835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of obesity on febrile urinary tract infection and renal scarring in children with vesicoureteral reflux.
    Byun HJ; Ha JY; Jung W; Kim BH; Park CH; Kim CI
    J Pediatr Urol; 2017 Feb; 13(1):67.e1-67.e6. PubMed ID: 28087230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vesicoureteral Reflux and Renal Scarring Risk in Children after the First Febrile Urinary Tract Infection.
    Yılmaz S; Özçakar ZB; Kurt Şükür ED; Bulum B; Kavaz A; Elhan AH; Yalçınkaya F
    Nephron; 2016; 132(3):175-80. PubMed ID: 26901769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal scarring is the most significant predictor of breakthrough febrile urinary tract infection in patients with simplex and duplex primary vesico-ureteral reflux.
    Loukogeorgakis SP; Burnand K; MacDonald A; Wessely K; De Caluwe' D; Rahman N; Farrugia MK
    J Pediatr Urol; 2020 Apr; 16(2):189.e1-189.e7. PubMed ID: 31953013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial prophylaxis for urinary tract infections: implications for adherence assessment.
    Gaither TW; Copp HL
    J Pediatr Urol; 2019 Aug; 15(4):387.e1-387.e8. PubMed ID: 31182400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Why Does Prevention of Recurrent Urinary Tract Infection not Result in Less Renal Scarring? A Deeper Dive into the RIVUR Trial.
    Wang HH; Kurtz M; Logvinenko T; Nelson C
    J Urol; 2019 Aug; 202(2):400-405. PubMed ID: 31026216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computer model predicting breakthrough febrile urinary tract infection in children with primary vesicoureteral reflux.
    Arlen AM; Alexander SE; Wald M; Cooper CS
    J Pediatr Urol; 2016 Oct; 12(5):288.e1-288.e5. PubMed ID: 27072485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis after acute pyelonephritis: a multicenter, randomized, controlled study.
    Garin EH; Olavarria F; Garcia Nieto V; Valenciano B; Campos A; Young L
    Pediatrics; 2006 Mar; 117(3):626-32. PubMed ID: 16510640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What is the risk of urinary tract infection in children with antenatally presenting dilating vesico-ureteric reflux?
    Evans K; Asimakadou M; Nwankwo O; Desai D; Cherian A; Mushtaq I; Cuckow P; Duffy P; Smeulders N
    J Pediatr Urol; 2015 Apr; 11(2):93.e1-6. PubMed ID: 25819378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predisposing factors for renal scarring in children with urinary tract infection.
    Beiraghdar F; Panahi Y; Einollahi B; Moharamzad Y; Nemati E; Amirsalari S
    Saudi J Kidney Dis Transpl; 2012 May; 23(3):532-7. PubMed ID: 22569440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of antimicrobial prophylaxis in the management of children with vesicoureteral reflux--the RIVUR study outcomes.
    Mathews R; Mattoo TK
    Adv Chronic Kidney Dis; 2015 Jul; 22(4):325-30. PubMed ID: 26088078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positioning irrigation of contrast cystography for diagnosis of occult vesicoureteric reflux: association with technetium-99m dimercaptosuccinic acid scans.
    Berger C; Becker T; Koen M; Zeino M; Fitz F; Beheshti M; Wolf-Kohlmeier I; Haim S; Riccabona M
    J Pediatr Urol; 2013 Dec; 9(6 Pt A):846-50. PubMed ID: 23219319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of febrile urinary tract infections in children after successful endoscopic treatment of vesicoureteral reflux: a long-term follow-up.
    Hunziker M; Mohanan N; D'Asta F; Puri P
    J Pediatr; 2012 Jun; 160(6):1015-20. PubMed ID: 22284917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sonographic assessment of the effect of vesicoureteral reflux and urinary tract infections on growth of the pediatric solitary kidney.
    Ross I; Ahn HJ; Roelof B; Barber T; Huynh V; Rockette A; Popovic M; Chen JJ; Steinhardt G
    J Pediatr Urol; 2015 Jun; 11(3):145.e1-6. PubMed ID: 25864614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationale and design issues of the Randomized Intervention for Children With Vesicoureteral Reflux (RIVUR) study.
    Keren R; Carpenter MA; Hoberman A; Shaikh N; Matoo TK; Chesney RW; Matthews R; Gerson AC; Greenfield SP; Fivush B; McLurie GA; Rushton HG; Canning D; Nelson CP; Greenbaum L; Bukowski T; Primack W; Sutherland R; Hosking J; Stewart D; Elder J; Moxey-Mims M; Nyberg L
    Pediatrics; 2008 Dec; 122 Suppl 5(Suppl 5):S240-50. PubMed ID: 19018048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The RIVUR trial: a factual interpretation of our data.
    Mattoo TK; Carpenter MA; Moxey-Mims M; Chesney RW;
    Pediatr Nephrol; 2015 May; 30(5):707-12. PubMed ID: 25558811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.